Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Blom

Showing results (681-690 of 717) with videos related to

Pageof 72
Sort By:
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Lancet (London, England)|November 6, 2012
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyMarina Cuchel, Emma A Meagher, Hendrik du Toit Theron, et al.
Journal of Inherited Metabolic Disease|April 11, 2019
Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari populationNader Al-Dewik, Alaa Ali, Yassmin Mahmoud, et al.
Atherosclerosis|April 22, 2015
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trialC Stefanutti, D J Blom, M R Averna, et al.
American Journal of Human Genetics|February 12, 2011
Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiencySiddharth Banka, Henk J Blom, John Walter, et al.
Nature Communications|September 13, 2019
A highly conductive fibre network enables centimetre-scale electron transport in multicellular cable bacteriaFilip J R Meysman, Rob Cornelissen, Stanislav Trashin, et al.
Psychological Medicine|November 4, 2024
Comparative efficacy of interpersonal psychotherapy and antidepressant medication for adult depression: a systematic review and individual participant data meta-analysisZachary D Cohen, Jasmijn Breunese, John C Markowitz, et al.
American Journal of Preventive Cardiology|April 29, 2025
Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practiceMitchell N Sarkies, Gerald F Watts, Samuel S Gidding, et al.
Pageof 72

Showing results (681-690 of 717) with videos related to

Sort By:
Pageof 72
JAMA Cardiology|February 14, 2024
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial HypercholesterolemiaJanneke W C M Mulder, Tycho R Tromp, Mutaz Al-Khnifsawi, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape TownRoeland Huijgen, Dirk J Blom, Merel L Hartgers, et al.
Lancet (London, England)|November 6, 2012
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyMarina Cuchel, Emma A Meagher, Hendrik du Toit Theron, et al.
Journal of Inherited Metabolic Disease|April 11, 2019
Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari populationNader Al-Dewik, Alaa Ali, Yassmin Mahmoud, et al.
Atherosclerosis|April 22, 2015
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trialC Stefanutti, D J Blom, M R Averna, et al.
American Journal of Human Genetics|February 12, 2011
Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiencySiddharth Banka, Henk J Blom, John Walter, et al.
Nature Communications|September 13, 2019
A highly conductive fibre network enables centimetre-scale electron transport in multicellular cable bacteriaFilip J R Meysman, Rob Cornelissen, Stanislav Trashin, et al.
Psychological Medicine|November 4, 2024
Comparative efficacy of interpersonal psychotherapy and antidepressant medication for adult depression: a systematic review and individual participant data meta-analysisZachary D Cohen, Jasmijn Breunese, John C Markowitz, et al.
American Journal of Preventive Cardiology|April 29, 2025
Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practiceMitchell N Sarkies, Gerald F Watts, Samuel S Gidding, et al.
Pageof 72